To broaden the appeal of therapist-assisted psychedelics, a number of companies are engineering out the hallucinogenic aspect. The post Researchers Seek...
Nenad Grmusa Nenad Grmusa was “really happy” at Takeda, where he’d been for more than a decade in various R&D strategy and finance positions....
The first thing anyone should know about psychedelic stocks is that it is a long game. If you are expecting a quick turn in profit for...
The article Atai Life Sciences Launches Phase 1 MDMA Trial was originally published on Microdose. “We continue to execute on our pipeline – having...
CHAPEL HILL, N.C., September 23, 2022 – While illegal for recreational use, psychedelic drugs are showing great promise as treatments for severe depression...
Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics™, is pleased to announce...
The article Cybin Buys License to Mindset Pharma’s Psychedelic Compounds was originally published on Microdose. Cybin Obtains Exclusive License to a...
Universal Ibogaine Inc.(TSXV:IBO), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce...
The article News You Might Have Missed: Sep 26th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
CaaMTech scientists, in collaboration with the Manke Lab at UMass Dartmouth, recently reported their synthesis and structural characterization of two...